This study reveals that EGFR–SGLT1 may confer a survival advantage to cancer cells by maintaining a basal level of intracellular glucose and preventing autophagy.
这项研究说明了EGFR–SGLT1通路通过维持细胞内的葡萄糖水平，阻止自噬性细胞死亡，从而为肿瘤细胞提供了生存优势。
This study reveals that EGFR–SGLT1 may confer a survival advantage to cancer cells by maintaining a basal level of intracellular glucose and preventing autophagy.
这项研究说明了EGFR–SGLT1通路通过维持细胞内的葡萄糖水平，阻止自噬性细胞死亡，从而为肿瘤细胞提供了生存优势。
应用推荐